Belite Bio (BLTE) Earnings Date, Estimates & Call Transcripts $64.40 -0.80 (-1.23%) Closing price 04:00 PM EasternExtended Trading$64.98 +0.58 (+0.90%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Belite Bio Earnings Summary Belite Bio released Q2 2025 earnings on August 11, 2025, reporting an EPS of -$0.50, which missed analysts' consensus estimates of -$0.47 by $0.03. With a trailing EPS of -$1.55, Belite Bio's earnings are expected to grow next year, from ($1.17) to ($0.83) per share. Latest Q2 Earnings DateAug. 11EstimatedConsensus EPS (Aug. 11) -$0.47 Actual EPS (Aug. 11) -$0.50 Missed By -$0.03 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (6-K) Slide DeckSlide DeckFull Screen Slide DeckPowered by Get Belite Bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Belite Bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBLTE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Belite Bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.37-$0.37-$0.37Q2 20252-$0.48-$0.46-$0.47Q3 20252-$0.54-$0.53-$0.54Q4 20252-$0.56-$0.53-$0.55 FY 2025 7 -$1.95 -$1.89 -$1.92 Q1 20261-$0.52-$0.52-$0.52Q2 20261-$0.52-$0.52-$0.52Q3 20261-$0.50-$0.50-$0.50Q4 20261-$0.50-$0.50-$0.50 Belite Bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/11/2025Q2 2025-$0.47-$0.50 -$0.03-$0.50--3/17/2025Q4 2024-$0.30-$0.32 -$0.02-$0.32--11/12/2024Q3 2024-$0.30-$0.28+$0.02-$0.28--8/9/2024Q2 2024-$0.28-$0.31 -$0.03-$0.31--5/13/2024Q1 2024-$0.34-$0.27+$0.07-$0.27--3/11/2024Q4 2023-$0.36-$0.25+$0.11-$0.25--11/13/2023Q3 2023-$0.31-$0.40 -$0.09-$0.40-- Belite Bio Earnings - Frequently Asked Questions When did Belite Bio announce their last quarterly earnings? Belite Bio (NASDAQ:BLTE) last announced its quarterly earning data on Monday, August 11, 2025. Learn more on BLTE's earnings history. Did Belite Bio beat their earnings estimates last quarter? In the previous quarter, Belite Bio (NASDAQ:BLTE) missed the analysts' consensus estimate of ($0.47) by $0.03 with a reported earnings per share (EPS) of ($0.50). Learn more on analysts' earnings estimate vs. BLTE's actual earnings. How can I listen to Belite Bio's earnings conference call? The conference call for Belite Bio's latest earnings report can be listened to online. Listen to Conference Call How can I read Belite Bio's conference call transcript? The conference call transcript for Belite Bio's latest earnings report can be read online. Read Transcript How much profit does Belite Bio generate each year? Belite Bio (NASDAQ:BLTE) has a recorded net income of -$36.14 million. BLTE has generated -$1.55 earnings per share over the last four quarters. What is Belite Bio's EPS forecast for next year? Belite Bio's earnings are expected to grow from ($1.17) per share to ($0.83) per share in the next year. More Earnings Resources from MarketBeat Related Companies Blueprint Medicines Earnings Date Roivant Sciences Earnings Date Legend Biotech Earnings Date Revolution Medicines Earnings Date Rhythm Pharmaceuticals Earnings Date Avidity Biosciences Earnings Date Nuvalent Earnings Date Axsome Therapeutics Earnings Date CRISPR Therapeutics Earnings Date Merus Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Earnings Miss, Walmart Is Still a Top Consumer Staples PlayRoyal Caribbean Earnings Beat Fuels Strong 2025 OutlookDLocal Stock Soars 43% After Earnings Beat and Raised GuidanceGreen Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity This page (NASDAQ:BLTE) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Belite Bio, Inc. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Belite Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access